← Back to Search

Antiplatelet Agent

ASA 81mg for Colorectal Cancer

Phase 2
Waitlist Available
Led By Robert Hilsden
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at enrollment
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group

Summary

This trial is testing whether a real-world chemoprevention agent (CPA) intervention (3-months of daily low-dose acetylsalicylic (ASA)) is feasible in participants at increased risk for colorectal cancer (CRC).

Eligible Conditions
  • Colorectal Cancer
  • Colorectal Polyps
  • Colorectal Adenomas

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to ASA over 90 days
Adherence to at least 50 percent of total prescribed dose
Measurement of Adverse Events
+1 more
Secondary study objectives
Factors related to uptake and adherence to ASA
Aspirin
Factors related to uptake and adherence to ASA using measurement of self efficacy
+2 more

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ASA 81mgExperimental Treatment1 Intervention
Acetylsalicylic acid delayed release tablets (81mg), single tablet taken once per day for 90 days.

Find a Location

Who is running the clinical trial?

Canadian Cancer Society (CCS)OTHER
81 Previous Clinical Trials
41,315 Total Patients Enrolled
University of CalgaryLead Sponsor
808 Previous Clinical Trials
884,289 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,386 Previous Clinical Trials
26,515,875 Total Patients Enrolled
~30 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top